Life Sciences

Driving Discovery. Improving Lives.

The NYC life sciences community is launching dynamic new startups and leading scientific breakthroughs that are improving health outcomes and powerfully enhancing our basic quality of life. These enterprises are developing technologies that protect patients from infection, researching new therapeutic approaches to treat cancer, and creating new tools and medicines to fight currently untreatable diseases.

NYC’s life sciences assets include:

• Nine major academic medical centers
• $2.0 billion in annual National Institutes of Health (NIH) awards in 2020—an all-time high
• 7,000+ graduate students and postdocs at universities
• A 400 percent increase in private venture capital funding for the industry from 2016 to 2018
• The largest biotech workforce in the country
• Six incubators to support early-stage life sciences companies

These assets, and the City's commitment to investing in this growth sector, have made life sciences a cornerstone of the NYC economy. The industry now contributes $3.1B to the city's gross metropolitan product and has seen an average annual growth of 50+ companies since 2016.

Leading the Way in Life Sciences Innovation

New York City is building on its existing strengths and investing in the spaces, companies, and talent that will produce life-saving cures and treatments, while catalyzing new opportunities for all New Yorkers.